ePROPP - eHealth for Preventing and Reducing Orofacial Pain in the Population

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMalmö University

About this trial

Pain in the orofacial region has a 10% prevalence in the general population and health care providers are therefore expected to encounter these patients on a daily basis. Chronic orofacial pain often presents as jaw pain related to overload of the jaw muscles and temporomandibular joints. The aim of this study is to evaluate the effectiveness of a smartphone-based behavioural intervention (Ecological Momentary Intervention, EMI) grounded in Cognitive Behavioural Therapy (CBT), compared to standard treatment with an occlusal splint and a waiting list control group.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Chronic orofacial pain, duration ≥3 months with a diagnosis of Myalgia according to the brief DC/TMD.

Patients will be included even if they have one or more additional DC/TMD diagnoses

Regular smartphone users

Understanding written and spoken Swedish

Disqualifiers

Other orofacial non-TMD pain conditions

Cognitive impairment.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mobistudy Application

    Behavioral

    Treatment with mobile application

  • Occlusal splint

    Device

    Treatment with an occlusal splint

Treatment groups

120 Participants
are divided into 3 treatment groups
Group A: Mobistudy ApplicationExperimental treatment 1 intervention
Group B: Occlusal splintActive comparator 1 intervention
Group C: Waiting listNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in pain intensity

Pain level will be assessed using the Numeric rating Scale (NRS, a scale ranging from 0 (no pain) to 10 (worst pain imaginable). A 30% reduction in pain according to the NRS is considered a significant effect.

Time frame
From enrolment to 3 month follow-up

Secondary outcomes

1

Cost-effectiveness

Cost-effectiveness will be assessed using direct and indirect costs to calculate total societal costs for the two different interventions

Time frame
From enrolment to 3 month follow-up
2

Stress-levels

Assessment of stress will be done using the Perceived stress-scale (PSS-10) which yields a total score from 0 to 40, calculated by summing responses to 10 items, each scored on a 5-point Likert scale (0 = never to 4 = very often).

Time frame
From enrolment to 3 month follow-up
3

Changes in general well-being

Assessment of general wellbeing will be done with Patient Health Questionnaire (PHQ-4) which combines two 2-item scales: the PHQ-2 (depression) and the GAD-2 (anxiety). Each question is scored on a 4-point Likert scale (0-3), and the total score is the sum of all four items Higher scores indicate a greater severity of symptoms.

Time frame
From enrolment to 3 month follow-up
4

Correlation between pain and overload

During the first 3 days of using the mobistudy application, the relation between muscluskeletal overload and TMD-pain will be assessed.. Assessment of overload with Ecological momentary assessment of self-reported overload will be correlated (Spearman's correlated) to pain intensity using the Numeric rating Scale (NRS), a scale ranging from 0 (no pain) to 10 (worst pain imaginable).

Time frame
From enrolment to 3 month follow-up

Other outcomes

1

Coping

Coping will be assessed with the Brief Resilience Coping Scale (BRCS-4) using a 5-point Likert scale for each item, ranging from "Does not describe me at all" to "Describes me very well". The total score is calculated by summing the responses to all four items. Higher scores indicate a greater tendency toward resilient coping.

Time frame
From enrolment to 3 month follow-up
2

Headache

Assessment with the Headache screening questionnaire (HSQ). The HSQ aims to identify individuals who might have migraine or tension type headache by assessing headache characteristics across four domains: frequency, duration, characteristics, and symptoms.

Time frame
From enrolment to 3 month follow-up
3

Widespread pain

Widespread pain will be assessed by a pain manikin.

Time frame
From enrolment to 3 month follow-up

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Malmö University

Lead sponsor

Folktandvården Skåne AB

Collaborator

This trial is not recruiting at the moment. You can still explore other options: